APA (7th ed.) Citation

Li Tao, Xiangyu Xia, Shujing Kong, Tingye Wang, Fangtian Fan, & Weimin Wang. (2024). Natural pentacyclic triterpenoid from Pristimerin sensitizes p53-deficient tumor to PARP inhibitor by ubiquitination of Chk1. Elsevier.

Chicago Style (17th ed.) Citation

Li Tao, Xiangyu Xia, Shujing Kong, Tingye Wang, Fangtian Fan, and Weimin Wang. Natural Pentacyclic Triterpenoid from Pristimerin Sensitizes P53-deficient Tumor to PARP Inhibitor by Ubiquitination of Chk1. Elsevier, 2024.

MLA (9th ed.) Citation

Li Tao, et al. Natural Pentacyclic Triterpenoid from Pristimerin Sensitizes P53-deficient Tumor to PARP Inhibitor by Ubiquitination of Chk1. Elsevier, 2024.